Health · 16 September 2026
Diabetes drug metformin may slow aging processes, new review suggests
Image by Towfiqu Barbhuiya on Freepik
Researchers are looking into whether metformin, a common diabetes drug, could affect biological aging processes, not just blood sugar. A new review found strong evidence linking the drug to cellular functions involved in aging, like nutrient sensing and mitochondrial health. However, longer human trials are needed to confirm if it truly slows aging or just reduces disease risks.
Reported by SciTechDaily · How we write briefs